Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Teleflex Inc Stock Research

TFX

204.02USD+0.56(+0.28%)Market Closed
Watchlist

Market Summary

USD204.02+0.56
Market Closed
0.28%

TFX Stock Price

TFX RSI Chart

TFX Valuation

Market Cap

9.6B

Price/Earnings (Trailing)

26.01

Price/Sales (Trailing)

3.31

EV/EBITDA

15.79

Price/Free Cashflow

29.45

TFX Price/Sales (Trailing)

TFX Profitability

EBT Margin

15.73%

Return on Equity

8.83%

Return on Assets

5.24%

Free Cashflow Yield

3.4%

TFX Fundamentals

TFX Revenue

Revenue (TTM)

2.9B

Revenue Y/Y

5.5%

Revenue Q/Q

4.55%

TFX Earnings

Earnings (TTM)

368.6M

Earnings Y/Y

5.52%

Earnings Q/Q

45.07%

Price Action

52 Week Range

182.37276.43
(Low)(High)

Last 7 days

-4.4%

Last 30 days

-6.2%

Last 90 days

-14.0%

Trailing 12 Months

-3.6%

TFX Financial Health

Current Ratio

2.48

TFX Investor Care

Dividend Yield

0.67%

Dividend/Share (TTM)

1.36

Shares Dilution (1Y)

0.17%

Diluted EPS (TTM)

7.8

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for TFX

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-08-09
Kelly Liam
gifted
-
-
5,768
chairman, president & ceo
2023-08-09
Kelly Liam
gifted
-
-
-5,768
chairman, president & ceo
2023-05-10
RANDLE STUART A
sold
-742,290
245
-3,021
-
2023-05-10
RANDLE STUART A
acquired
305,484
101
3,021
-
2023-05-09
Klasko Stephen K. M.D.
acquired
-
-
681
-
2023-05-09
RANDLE STUART A
acquired
-
-
527
-
2023-05-09
Patil Neena M
acquired
-
-
527
-
2023-05-09
Krakauer Andrew A
acquired
-
-
527
-
2023-05-09
HEINMILLER JOHN C
acquired
-
-
527
-
2023-05-09
HAGGERTY GRETCHEN R
acquired
-
-
527
-

1–10 of 50

Which funds bought or sold TFX recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-20
BARCLAYS PLC
added
89.52
8,543,000
19,082,000
0.01%
2023-09-12
Farther Finance Advisors, LLC
added
43.48
2,161
7,987
-%
2023-08-30
Western Wealth Management, LLC
added
15.72
38,976
406,235
0.04%
2023-08-28
DT Investment Partners, LLC
unchanged
-
-249
2,493
-%
2023-08-24
Alberta Investment Management Corp
unchanged
-
-13,536
290,436
-%
2023-08-21
OSAIC HOLDINGS, INC.
added
7.7
36,356
1,281,300
-%
2023-08-21
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
reduced
-75.99
-3,422,000
1,019,000
0.01%
2023-08-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-2.19
-1,275,470
18,214,500
0.03%
2023-08-21
BOKF, NA
added
3.12
-4,673
312,218
0.01%
2023-08-17
Coppell Advisory Solutions LLC
new
-
1,410
1,410
-%

1–10 of 47

Latest Funds Activity

Are funds buying TFX calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own TFX
No. of Funds

Schedule 13G FIlings of Teleflex

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
t. rowe price investment management, inc.
18.4%
8,633,473
SC 13G/A
Feb 09, 2023
vanguard group inc
11.56%
5,420,563
SC 13G/A
Feb 06, 2023
wellington management group llp
6.59%
3,092,719
SC 13G/A
Feb 03, 2023
blackrock inc.
8.5%
3,969,361
SC 13G/A
Feb 14, 2022
price t rowe associates inc /md/
13.8%
6,494,778
SC 13G/A
Feb 10, 2022
vanguard group inc
10.81%
5,063,204
SC 13G/A
Feb 04, 2022
wellington management group llp
7.11%
3,331,136
SC 13G/A
Jan 27, 2022
blackrock inc.
10.4%
4,856,339
SC 13G/A
Jan 25, 2022
blackrock inc.
10.4%
4,856,339
SC 13G/A
Sep 10, 2021
price t rowe associates inc /md/
15.6%
7,305,896
SC 13G/A

Recent SEC filings of Teleflex

View All Filings
Date Filed Form Type Document
Aug 31, 2023
8-K
Current Report
Aug 11, 2023
4
Insider Trading
Aug 03, 2023
8-K
Current Report
Aug 03, 2023
10-Q
Quarterly Report
Jun 26, 2023
11-K
Employee Benefit Details

TFX Fair Value

Loading...

Peers (Alternatives to Teleflex)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
108.3B
19.5B
3.38% 36.58%
39.99
5.57
10.36% 30.30%
101.2B
6.7B
-0.75% 50.83%
71.05
15.19
11.75% -0.66%
77.5B
13.4B
6.45% 36.39%
85
5.78
8.69% 3.17%
71.3B
19.0B
-4.29% 12.66%
44.09
3.79
0.46% -5.24%
42.3B
5.7B
-8.22% -17.24%
30.48
7.49
5.64% -4.53%
MID-CAP
9.5B
937.8M
-2.12% 37.22%
325.65
10.11
16.30% 250.21%
7.1B
616.6M
-12.54% -24.86%
29.24
11.56
69.52% 343.68%
5.1B
1.1B
-6.10% -12.07%
24.23
4.65
12.63% 50.85%
2.6B
452.1M
-21.20% -33.94%
-26.32
5.78
24.99% 24.09%
1.3B
790.3M
-27.09% -56.49%
-5.97
1.69
3.21% -1604.53%
SMALL-CAP
1.6B
421.8M
-15.15% 56.11%
-9.32
3.69
44.49% -2.43%
947.4M
780.7M
-7.75% -9.65%
-26.32
1.21
4.68% -510.17%
839.3M
239.8M
0.70% 0.15%
-22.16
3.5
-4.74% -31.15%
609.7M
162.9M
-27.67% -61.65%
-11.53
3.74
42.67% 12.82%

Teleflex News

MarketWatch
Teleflex Inc. stock underperforms Thursday when compared to competitors.
MarketWatch,
2 days ago

Returns for TFX

Cumulative Returns on TFX

10.3%


10-Year Cumulative Returns

3.0%


7-Year Cumulative Returns

-5.1%


5-Year Cumulative Returns

-14.7%


3-Year Cumulative Returns

Risks for TFX

What is the probability of a big loss on TFX?

57.3%


Probability that Teleflex stock will be more than 20% underwater in next one year

48.5%


Probability that Teleflex stock will be more than 30% underwater in next one year.

13.8%


Probability that Teleflex stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does TFX drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Teleflex was unfortunately bought at previous high price.

Drawdowns

Financials for Teleflex

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Revenue1.4%2,8992,8602,7912,7952,8082,8172,8102,7592,6872,5402,5372,5072,5272,6122,5952,5562,5172,4752,4482,4022,327
Gross Profit1.2%1,5951,5761,5311,5291,5431,5511,5501,5131,4551,3361,3251,3191,3451,4191,4091,3971,3851,3771,3841,3491,302
  S&GA Expenses0.7%899893864858854861860865832799744731768793852769774789797873822
  R&D Expenses1.6%16115915414714113713112912612212011711611411411110910710610499.00
EBITDA-100.0%-580567594705853854786676598651791738766639------
EBITDA Margin-100.0%-0.20*0.20*0.21*0.25*0.30*0.30*0.28*0.25*0.24*0.26*0.32*0.29*0.29*0.25*------
Interest Expenses10.2%69.0062.0054.0047.0046.0051.0057.0064.0068.0068.0066.0065.0068.0073.0080.0086.0094.0010010310398.00
Earnings Before Taxes0.7%453450446480590566559493379303358382365429340335291211220191225
EBT Margin-100.0%-0.16*0.16*0.17*0.21*0.20*0.20*0.18*0.14*0.12*0.14*0.15*0.14*0.16*0.13*------
Net Income1.6%36936336341351048848543335127933536748055246144427118620168.0088.00
Net Income Margin-100.0%-0.13*0.13*0.15*0.18*0.17*0.17*0.16*0.13*0.11*0.13*0.15*0.19*0.21*0.18*------
Free Cashflow-100.0%-277264374422538581566480469346308328267334------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Assets-0.3%6,8966,9186,9286,7586,7326,8736,8727,0407,0667,0287,1536,6136,7656,7026,3106,2576,3146,2686,2786,2016,175
  Current Assets1.2%1,4461,4281,4111,4591,3851,4941,4291,5421,4371,3791,4221,4211,5451,4471,3061,2381,2451,1831,2361,2411,185
    Cash Equivalents-5.0%251264292397308467445481362325376347554406301258304271357356346
  Inventory2.8%632614579530511491478484490512513526515489477473461446428411405
  Net PPE1.3%465459447422429436444446450468474445432427431430425410433421411
  Goodwill-0.1%2,5462,5482,53771.002,4612,4932,5042,5232,5372,5662,5862,3642,3442,3322,2452,2312,2502,2482,24730.002,221
Liabilities-4.5%2,6812,8082,9062,8632,8793,0783,1173,3823,6003,6523,8163,3773,6683,6293,3313,4043,6503,6983,7383,6943,741
  Current Liabilities-3.5%555576581611610656680562527508540475457402563530494521582549536
    LT Debt, Non Current-5.1%1,4711,5491,6241,5941,6061,7411,7401,9492,2162,2952,3782,0362,3292,3411,8591,9492,0812,0732,0722,0762,145
Shareholder's Equity2.6%4,2154,1104,0223,8953,8533,7963,7553,6583,4663,3763,3363,2363,0973,0732,9792,8532,6652,5702,5402,5072,434
  Retained Earnings---3,817---3,518---3,096---2,825---2,428--
  Additional Paid-In Capital---715---693---652---617---575--
Shares Outstanding0.1%47.0047.00-47.0047.0047.00-47.0047.0047.00-47.0046.0046.00-46.0046.0046.00-46.0046.00
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Cashflow From Operations12.7%412365343446489603652646568559437389414365437421411408435410410
  Share Based Compensation-1.7%28.0029.0027.0026.0024.0023.0023.0023.0024.0023.0021.0022.0023.0025.0027.0026.0024.0023.0022.0021.0021.00
Cashflow From Investing9.1%-244-268-259-68.20144165157-351-574-574-837-318-320-334-73.48-191-183-200-196-852-869
Cashflow From Financing21.2%-228-290-217-415-649-605-715-161-197-81.664558.00161111-418-317-271-298-206-213121
  Dividend Payments0.0%64.0064.0064.0064.0064.0064.0064.0064.0063.0063.0063.0063.0063.0063.0063.0063.0063.0062.0062.0062.0062.00

TFX Income Statement

2023-07-02
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended6 Months Ended
Jul. 02, 2023
Jun. 26, 2022
Jul. 02, 2023
Jun. 26, 2022
Income Statement [Abstract]    
Net revenues$ 743,259$ 704,542$ 1,454,191$ 1,346,257
Cost of goods sold335,436315,709654,988611,191
Gross profit407,823388,833799,203735,066
Selling, general and administrative expenses223,306216,825456,022420,757
Research and development expenses39,44836,93480,91773,294
Restructuring and impairment charges (credits)1,508(83)3,7292,322
Income from continuing operations before interest and taxes143,561135,157258,535238,693
Interest expense17,76211,41936,09921,837
Interest income(1,156)(229)(1,999)(451)
Income from continuing operations before taxes126,955123,967224,435217,307
Taxes on income from continuing operations15,53218,41235,71634,385
Income from continuing operations111,423105,555188,719182,922
Operating loss from discontinued operations(114)(54)(825)(348)
Tax benefit on operating loss from discontinued operations(26)(13)(189)(81)
Loss from discontinued operations(88)(41)(636)(267)
Net income$ 111,335$ 105,514$ 188,083$ 182,655
Basic:    
Income from continuing operations (in dollars per share)$ 2.37$ 2.25$ 4.02$ 3.90
Loss from discontinued operations (in dollars per share)00(0.02)0
Net income (in dollars per share)2.372.254.003.90
Diluted:    
Income from continuing operations (in dollars per share)2.352.233.993.86
Loss from discontinued operations (in dollars per share)00(0.01)0
Net income (in dollars per share)$ 2.35$ 2.23$ 3.98$ 3.86
Weighted average common shares outstanding    
Basic (in shares)46,98146,90146,96546,889
Diluted (in shares)47,32947,34747,30747,374

TFX Balance Sheet

2023-07-02
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jul. 02, 2023
Dec. 31, 2022
Current assets  
Cash and cash equivalents$ 250,816$ 292,034
Accounts receivable, net429,309408,834
Inventories631,555578,507
Prepaid expenses and other current assets120,190125,084
Prepaid taxes13,9296,524
Total current assets1,445,7991,410,983
Property, plant and equipment, net464,609447,205
Operating lease assets123,215131,211
Goodwill2,546,1302,536,730
Intangible assets, net2,227,9472,306,165
Deferred tax assets6,2786,402
Other assets81,74789,367
Total assets6,895,7256,928,063
Current liabilities  
Current borrowings87,50087,500
Accounts payable142,081126,807
Accrued expenses127,861140,644
Payroll and benefit-related liabilities106,177133,092
Accrued interest5,7935,332
Income taxes payable20,18424,736
Other current liabilities65,85363,381
Total current liabilities555,449581,492
Long-term borrowings1,470,6741,624,023
Deferred tax liabilities385,113388,886
Pension and postretirement benefit liabilities30,68631,394
Noncurrent liability for uncertain tax positions6,5345,805
Noncurrent operating lease liabilities112,229120,437
Other liabilities119,948154,058
Total liabilities2,680,6332,906,095
Commitments and contingencies
Total shareholders' equity4,215,0924,021,968
Total liabilities and shareholders' equity$ 6,895,725$ 6,928,063
Liam J. Kelly
14000
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.